Pliant Therapeutics, Inc. (PLRX)
NASDAQ·Healthcare·Biotechnology
$0.82
-0.48%
Mkt Cap $65.64M
Analyst Ratings
No recent rating data.
Price Target (11 analysts)
$25.86
Range $2.00 – $48.00
Implied Upside
+3052.0%
Consensus $25.86 vs current $0.82
NASDAQ·Healthcare·Biotechnology
$0.82
-0.48%
Mkt Cap $65.64M
No recent rating data.
Price Target (11 analysts)
$25.86
Range $2.00 – $48.00
+3052.0%
Consensus $25.86 vs current $0.82